Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Atividade Física Virtual Exercício Sentado - Fase 2 (V-PASE)

18 de setembro de 2026 atualizado por: Janice Eng, University of British Columbia

Assessing a Telehealth Seated Exercise Program on Post-stroke Balance and Mobility: A Mixed-method Design

This study will determine the acceptability of delivering seated exercises online and if seated exercises can improve balance, mobility, quality of life, and cardiometabolic health in those living with a stroke related mobility impairment.

Participants will be allocated to either a 10-week seated exercise program or a delayed 2-week Boot Camp program. All seated exercises sessions and assessments will be conducted virtually.

Visão geral do estudo

Status

Ativo, não recrutando

Descrição detalhada

The study will be a virtual 10-week multi-site, assessor-blinded, randomized controlled trial with an embedded qualitative component. The study will be conducted in real time using secure videoconferencing software (Zoom). Participants will be randomized 1:1 to a 10-week Seated Exercise group or a delayed 2-week Seated Exercise Group (Boot Camp). Seated exercise sessions will be delivered and supervised by a trained instructor.

Participants will use their own computer, laptop, or tablet for the zoom sessions. No Zoom sessions will be recorded. Caregivers will be invited to attend each exercise session to provide support and assistance but are not obliged to attend. A caregiver, friend, or family member will be required for each assessment to participate in the study.

Tipo de estudo

Intervencional

Inscrição (Estimado)

100

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • British Columbia
      • Vancouver, British Columbia, Canadá, V5Z 2G9
        • GF Strong Rehabilitation Centre
    • Manitoba
      • Winnipeg, Manitoba, Canadá
        • University of Manitoba
    • Nova Scotia
      • Halifax, Nova Scotia, Canadá
        • Nova Scotia Health
    • Ontario
      • London, Ontario, Canadá
        • Western University
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canadá
        • University of Saskatchewan

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

Participants must meet the following inclusion criteria:

  • Adult (as defined by Province)
  • Chronic stroke (more than 6 months post-stroke)
  • Ability to stand up from a chair
  • Mobility impairment of lower extremity (requires a walking aid, with or without close supervision)
  • Able to safely engage in exercise and tolerate 60 minutes of exercises
  • Able to communicate in English
  • Have access to a tablet, computer, or laptop with internet and email access

Exclusion Criteria:

Participants will be excluded if they meet any of the following criteria:

  • Participating in formal exercise or rehabilitation activities
  • Participating in > 30 minutes/day of physical activity (moderate intensity)
  • Participating in another study that may affect outcomes to this study
  • Severe loss of vision, hearing, speech (including aphasia) or cognition that would preclude use of a computer/tablet and communication over videoconference software
  • A serious comorbid condition (eg., amputation, Parkinson's disease, active cancer)
  • Clinically diagnosed with acute/chronic illness or other condition which has known physical activity contraindications or limits their ability to complete each experimental condition (i.e., chronic low back pain aggravated by prolonged sitting)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: 10-week group

Will receive a 10-week seated exercise program, occurring 3 times per week. Sessions will be 60 minutes in duration.

The seated exercise program includes a variety of upper and lower limb strengthening, core strengthening, agility (fast arm and leg movements), and flexibility exercises. Participants will be supervised during each session thru videoconferencing by a trained instructor.

Sem intervenção: Delayed 2-week group (Boot Camp)

The Boot Camp group will complete a 2-week seated exercise program following the 10-week active trial period.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
30 Second Sit-to-Stand
Prazo: Immediately post-intervention (following 10-week trial)

Assessment of balance and lower extremity strength.

Immediately post-intervention (following 10-week trial)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Timed Up and Go
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

Participants stand up from a chair, walk 3 metres, turn around and then sit back down. The TUG assesses balance, mobility and turning ability

Immediately post-intervention, and retention (2-months post-intervention)
Tandem Stance
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

Measures balance in standing as reported in the Short Physical Performance Battery Protocol

Immediately post-intervention, and retention (2-months post-intervention)
Modified Telehealth Fugl-Meyer
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

The modified virtual Fugl-Meyer assess lower extremity impairments in those with stroke

Immediately post-intervention, and retention (2-months post-intervention)
Stroke Impact Scale
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

A self-reported measure of stroke-related disability. There are 8 domains with each item rated using a 5-point Likert scale, where lower scores mean greater difficulty to complete the item.

Immediately post-intervention, and retention (2-months post-intervention)
Activities-Specific Balance Confidence (ABC)
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

The ABC scale is a 16-item questionnaire where a participant rates their confidence in performing activities from 0% to 100% (higher percentages indicate greater self-efficacy).

Immediately post-intervention, and retention (2-months post-intervention)
Fatigue Severity Scale
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

Questionnaire assessing the impact of fatigue on daily tasks and activities. There are 9 questions, each scored from 1 to 7 (1 = strongly disagree; 7 = strong agreement).

Immediately post-intervention, and retention (2-months post-intervention)
Quality of Life (EQ-5D-5L)
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

The EQ-5D-5L assess self-care, mobility, depression/anxiety, pain, and usual activities. Each is scored with 5 levels (1=no problems, 5=major problems). Overall health on the day is scored from 0% (worst health) to 100% (best health).

Immediately post-intervention, and retention (2-months post-intervention)
Patient Health Questionnaire-4 (PHQ-4)
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

The PHQ-4 focuses on depression and anxiety. Questions are scored from 0 to 3 (0=not at all; 3 = Nearly every day).

Immediately post-intervention, and retention (2-months post-intervention)
Montreal Cognitive Assessment scale (MoCA-BLIND)
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

The MoCA-BLIND assess six different cognitive domains (excludes visual stimulus) over the phone: memory, attention, language, abstraction, delayed recall, and orientation. The MoCA-BLIND is scored from 0-22 (22 = no cognitive impairments).

Immediately post-intervention, and retention (2-months post-intervention)
Lipid Profiles
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
Fasting Glucose
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
Glucose (HbA1c)
Prazo: Immediately post-intervention, and retention (2-months post-intervention)

Blood samples will be collected following a 12-hour over-night fast

Immediately post-intervention, and retention (2-months post-intervention)
30 Second Sit-to-Stand
Prazo: Retention (2-months post-intervention)

Assessment of balance and lower extremity strength.

Retention (2-months post-intervention)

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Feasibility Indicator: Compliance
Prazo: Through study completion (approximately 10 weeks)

Percentage of participants that attend exercise sessions.

Through study completion (approximately 10 weeks)
Feasibility Indicator: Safety
Prazo: Through study completion (approximately 10 weeks)

Number of adverse events that occur during assessments or exercise sessions.

Through study completion (approximately 10 weeks)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

11 de outubro de 2023

Conclusão Primária (Estimado)

31 de dezembro de 2026

Conclusão do estudo (Estimado)

31 de março de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

17 de janeiro de 2023

Enviado pela primeira vez que atendeu aos critérios de CQ

1 de fevereiro de 2023

Primeira postagem (Real)

13 de fevereiro de 2023

Atualizações de registro de estudo

Última Atualização Postada (Real)

23 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

18 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever